257 related articles for article (PubMed ID: 24015775)
1. Long-term clinical response to cardiac resynchronisation therapy under a multidisciplinary model.
O'Donnell D; Lin T; Swale M; Rae P; Flannery D; Srivastava PM
Intern Med J; 2013 Nov; 43(11):1216-23. PubMed ID: 24015775
[TBL] [Abstract][Full Text] [Related]
2. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors of difficult implantation procedure in cardiac resynchronization therapy.
Bisch L; Da Costa A; Dauphinot V; Romeyer-Bouchard C; Khris L; M'baye A; Isaaz K
Europace; 2010 Aug; 12(8):1141-8. PubMed ID: 20573673
[TBL] [Abstract][Full Text] [Related]
4. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.
Bax JJ; Bleeker GB; Marwick TH; Molhoek SG; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
J Am Coll Cardiol; 2004 Nov; 44(9):1834-40. PubMed ID: 15519016
[TBL] [Abstract][Full Text] [Related]
6. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.
Pouleur AC; Knappe D; Shah AM; Uno H; Bourgoun M; Foster E; McNitt S; Hall WJ; Zareba W; Goldenberg I; Moss AJ; Pfeffer MA; Solomon SD;
Eur Heart J; 2011 Jul; 32(14):1720-9. PubMed ID: 21609974
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline.
Bleeker GB; Mollema SA; Holman ER; Van de Veire N; Ypenburg C; Boersma E; van der Wall EE; Schalij MJ; Bax JJ
Circulation; 2007 Sep; 116(13):1440-8. PubMed ID: 17785624
[TBL] [Abstract][Full Text] [Related]
8. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
[TBL] [Abstract][Full Text] [Related]
9. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).
Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP
JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685
[TBL] [Abstract][Full Text] [Related]
10. The left ventricular lead electrical delay predicts response to cardiac resynchronisation therapy.
Zhang H; Dai Z; Xiao P; Pan C; Zhang J; Hu Z; Chen S
Heart Lung Circ; 2014 Oct; 23(10):936-42. PubMed ID: 24996391
[TBL] [Abstract][Full Text] [Related]
11. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive imaging of cardiac venous anatomy with 64-slice multi-slice computed tomography and noninvasive assessment of left ventricular dyssynchrony by 3-dimensional tissue synchronization imaging in patients with heart failure scheduled for cardiac resynchronization therapy.
Van de Veire NR; Marsan NA; Schuijf JD; Bleeker GB; Wijffels MC; van Erven L; Holman ER; De Sutter J; van der Wall EE; Schalij MJ; Bax JJ
Am J Cardiol; 2008 Apr; 101(7):1023-9. PubMed ID: 18359325
[TBL] [Abstract][Full Text] [Related]
13. Clinical implication of right ventricular to left ventricular interlead sensed electrical delay in cardiac resynchronization therapy.
Kristiansen HM; Hovstad T; Vollan G; Keilegavlen H; Faerestrand S
Europace; 2012 Jul; 14(7):986-93. PubMed ID: 22308084
[TBL] [Abstract][Full Text] [Related]
14. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
[TBL] [Abstract][Full Text] [Related]
15. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
[TBL] [Abstract][Full Text] [Related]
16. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy.
Knappe D; Pouleur AC; Shah AM; Cheng S; Uno H; Hall WJ; Bourgoun M; Foster E; Zareba W; Goldenberg I; McNitt S; Pfeffer MA; Moss AJ; Solomon SD;
Circ Heart Fail; 2011 Jul; 4(4):433-40. PubMed ID: 21602574
[TBL] [Abstract][Full Text] [Related]
17. Paced left ventricular QRS width and ECG parameters predict outcomes after cardiac resynchronization therapy: PROSPECT-ECG substudy.
Hsing JM; Selzman KA; Leclercq C; Pires LA; McLaughlin MG; McRae SE; Peterson BJ; Zimetbaum PJ
Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):851-7. PubMed ID: 21956038
[TBL] [Abstract][Full Text] [Related]
18. Echocardiography-based qualification and response assessment to cardiac resynchronisation therapy in patients with chronic heart failure. The matrix metalloproteinase-9 substudy.
Szulik M; Stabryła-Deska J; Boidol J; Lenarczyk R; Kalarus Z; Kukulski T
Kardiol Pol; 2011; 69(10):1043-51. PubMed ID: 22006606
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of withdrawal of cardiac resynchronization therapy on left and right ventricular function, dyssynchrony, and contractile function in patients with New York Heart Association functional class I/II heart failure: MADIT-CRT.
Knappe D; Pouleur AC; Shah AM; Bourgoun M; Brown MW; Foster E; Pfeffer MA; Moss AJ; Solomon SD;
J Card Fail; 2013 Mar; 19(3):149-55. PubMed ID: 23482074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
